Cognitive improvement by SAK3 through T-type Ca2+ channel stimulation

被引：0
|
作者：
Yabuki, Yasushi [1 ]
Fukunaga, Kohji [1 ]
机构：
[1] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2016年 / 130卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
3-O-50
引用
收藏
页码：S123 / S123
页数：1
相关论文
共 50 条
  • [1] Pharmacological properties of SAK3, a novel T-type voltage-gated Ca2+ channel enhancer
    Yabuki, Yasushi
    Matsuo, Kazuya
    Izumi, Hisanao
    Haga, Hidaka
    Yoshida, Takashi
    Wakamori, Minoru
    Kakei, Akikazu
    Sakimura, Kenji
    Fukuda, Takaichi
    Fukunaga, Kohji
    NEUROPHARMACOLOGY, 2017, 117 : 1 - 13
  • [2] The memory improvement by T-type Ca2+ channel stimulation
    Fukunaga, Kohji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 48P - 48P
  • [3] T-Type Ca2+ Enhancer SAK3 Activates CaMKII and Proteasome Activities in Lewy Body Dementia Mice Model
    Xu, Jing
    Kawahata, Ichiro
    Izumi, Hisanao
    Fukunaga, Kohji
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [4] Alzheimer disease therapeutic candidate, SAK3 restores mouse adult neurogenesis through T-type calcium channel
    Sasaki, Yuzuru
    Yabuki, Yasushi
    Fukunaga, Kohji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S135 - S135
  • [5] Neuroprotective effect of T-type calcium channel activator, SAK3 on the transient brain ischemia.
    Xu, Jing
    Yabuki, Yasushi
    Fukunaga, Kohji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S107 - S107
  • [6] T-type calcium channel enhancer SAK3 enhances hippocampal neurogenesis in olfactory bulbectomized mice
    Yabuki, Yasushi
    Xu, Jing
    Fukunaga, Kohji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S129 - S129
  • [7] Inhibition of amyloid beta accumulation by T-type calcium channel enhancer SAK3 and its in vivo pharmacokinetics
    Izumi, Hisanao
    Shinoda, Yasuaru
    Fukunaga, Kohji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S165 - S165
  • [8] Alzheimer disease therapeutic candidate, SAK3 activates T-type calcium channel Cav3.1
    Yabuki, Yasushi
    Fukunaga, Kohji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S91 - S91
  • [9] Pharmacology of T-type Ca2+ channel blockers
    Tanaka, H
    Shigenobu, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 31P - 31P
  • [10] T-type Ca2+ channel antagonists and hypertension
    Xue, Quanfu
    Wang, Zhengang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 : S113 - S113
12345